UK toxicologist joins ToxStrategies
ToxStrategies is pleased to announce that Dr. Kristina Ulrich has joined our Biopharmaceuticals and Pharmaceuticals practice. Dr. Ulrich is a European Registered Toxicologist (ERT) and a… read more
Latest News
EpidStrategies Scientist on Leadership Panel
Dr. Naushin Hooda, an EpidStrategies Doctor of Pharmacy based in Toronto, will participate in a virtual panel discussion as part of the Canadian… read more
ToxStrategies scientist, Dr. Laurie Haws elected to Board of Directors
ToxStrategies scientist, Dr. Laurie Haws was recently elected to the Board of Directors for The Toxicology Forum. The Toxicology Forum is a leading… read more
ToxStrategies scientists publish systematic mapping and systematic reviews framework
ToxStrategies authors, Dr. Daniele Wikoff and Dr. Allison Franzen, and colleagues have published a framework for use of systematic mapping and systematic reviews in… read more
Ms. Ann Verwiel to present at ISES 30th Annual Meeting
ToxStrategies scientist, Ms. Ann Verwiel, will be presenting during the upcoming virtual 30th annual meeting of the International Society of Exposure Science. Ms…. read more
Dr. Laurie Haws to present at The Science of PFAS: Chemistry, Health and Multimedia Measurements Virtual Conference
ToxStrategies scientist, Dr. Laurie Haws, will be presenting in a virtual session at the upcoming Science of PFAS: Chemistry, Health, and Multimedia Measurements… read more
EpidStrategies and ToxStrategies review essential elements for a successful orphan drug program
EpidStrategies scientists have collaborated with toxicologists from ToxStrategies’ Biopharmaceuticals/Pharmaceuticals Practice to produce a white paper that provides “Critical insights into nonclinical toxicology and… read more
ToxStrategies-led team publishes study on Cr(VI) toxicity
ToxStrategies scientists published a GLP OECD designed reproductive toxicity study (Thompson et al., 2020) assessing the potential for adverse follicular effects in mice… read more